Cryofocus' Loss Narrows in H1

MT Newswires Live
08/11

Cryofocus Medtech (Shanghai)'s (HKG:6922) attributable loss narrowed to 23.8 million yuan in the first half from 52.2 million yuan in the year-ago period, according to a Friday filing with the Hong Kong bourse.

Shares fell 5% during the close of trading on Monday.

Loss per share at the medical device company narrowed to 0.10 yuan from 0.22 yuan in the prior-year period.

Operating income increased to 51.1 million yuan from 19.5 million yuan in the year-ago period.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10